Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.

The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.

A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.

The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.

The global market for Tetanus Vaccine was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tetanus Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tetanus Vaccine by region & country, by Type, and by Application.

The Tetanus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanus Vaccine.

Market Segmentation

Scope of Tetanus Vaccine - Market Report

Report Metric	Details
Report Name	Tetanus Vaccine - Market
CAGR	5%
Segment by Type:	Diphtheria and tetanus (DT) vaccines Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Tetanus and diphtheria (Td) vaccines Tetanus, diphtheria, and pertussis (Tdap) vaccines
Segment by Application	Adult Pediatric
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline plc, Pfizer,Inc, Merck & Co.,Inc, Sanofi Pasteur SA, Biological E, Dano Vaccine &Biological Pvt.Ltd.,, Panera, Shantha Biotechnics Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tetanus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tetanus Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Tetanus Vaccine - Market report?

Ans: The main players in the Tetanus Vaccine - Market are GlaxoSmithKline plc, Pfizer,Inc, Merck & Co.,Inc, Sanofi Pasteur SA, Biological E, Dano Vaccine &Biological Pvt.Ltd.,, Panera, Shantha Biotechnics Ltd

What are the Application segmentation covered in the Tetanus Vaccine - Market report?

Ans: The Applications covered in the Tetanus Vaccine - Market report are Adult, Pediatric

What are the Type segmentation covered in the Tetanus Vaccine - Market report?

Ans: The Types covered in the Tetanus Vaccine - Market report are Diphtheria and tetanus (DT) vaccines, Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines, Tetanus and diphtheria (Td) vaccines, Tetanus, diphtheria, and pertussis (Tdap) vaccines

1 Market Overview

1.1 Tetanus Vaccine Product Introduction

1.2 Global Tetanus Vaccine Market Size Forecast

1.2.1 Global Tetanus Vaccine Sales Value (2019-2030)

1.2.2 Global Tetanus Vaccine Sales Volume (2019-2030)

1.2.3 Global Tetanus Vaccine Sales Price (2019-2030)

1.3 Tetanus Vaccine Market Trends & Drivers

1.3.1 Tetanus Vaccine Industry Trends

1.3.2 Tetanus Vaccine Market Drivers & Opportunity

1.3.3 Tetanus Vaccine Market Challenges

1.3.4 Tetanus Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Tetanus Vaccine Players Revenue Ranking (2023)

2.2 Global Tetanus Vaccine Revenue by Company (2019-2024)

2.3 Global Tetanus Vaccine Players Sales Volume Ranking (2023)

2.4 Global Tetanus Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Tetanus Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Tetanus Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Tetanus Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Tetanus Vaccine

2.9 Tetanus Vaccine Market Competitive Analysis

2.9.1 Tetanus Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Tetanus Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Diphtheria and tetanus (DT) vaccines

3.1.2 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines

3.1.3 Tetanus and diphtheria (Td) vaccines

3.1.4 Tetanus, diphtheria, and pertussis (Tdap) vaccines

3.2 Global Tetanus Vaccine Sales Value by Type

3.2.1 Global Tetanus Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Tetanus Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Tetanus Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Tetanus Vaccine Sales Volume by Type

3.3.1 Global Tetanus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Tetanus Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Tetanus Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Tetanus Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adult

4.1.2 Pediatric

4.2 Global Tetanus Vaccine Sales Value by Application

4.2.1 Global Tetanus Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Tetanus Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Tetanus Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Tetanus Vaccine Sales Volume by Application

4.3.1 Global Tetanus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Tetanus Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Tetanus Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Tetanus Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Tetanus Vaccine Sales Value by Region

5.1.1 Global Tetanus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Tetanus Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Tetanus Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Tetanus Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Tetanus Vaccine Sales Volume by Region

5.2.1 Global Tetanus Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Tetanus Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Tetanus Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Tetanus Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Tetanus Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Tetanus Vaccine Sales Value, 2019-2030

5.4.2 North America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Tetanus Vaccine Sales Value, 2019-2030

5.5.2 Europe Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Tetanus Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Tetanus Vaccine Sales Value, 2019-2030

5.7.2 South America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Tetanus Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Tetanus Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Tetanus Vaccine Sales Value

6.2.1 Key Countries/Regions Tetanus Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Tetanus Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Tetanus Vaccine Sales Value, 2019-2030

6.3.2 United States Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Tetanus Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Tetanus Vaccine Sales Value, 2019-2030

6.4.2 Europe Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Tetanus Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Tetanus Vaccine Sales Value, 2019-2030

6.5.2 China Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Tetanus Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Tetanus Vaccine Sales Value, 2019-2030

6.6.2 Japan Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Tetanus Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Tetanus Vaccine Sales Value, 2019-2030

6.7.2 South Korea Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Tetanus Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Tetanus Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Tetanus Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Tetanus Vaccine Sales Value, 2019-2030

6.9.2 India Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Tetanus Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline plc

7.1.1 GlaxoSmithKline plc Company Information

7.1.2 GlaxoSmithKline plc Introduction and Business Overview

7.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GlaxoSmithKline plc Tetanus Vaccine Product Offerings

7.1.5 GlaxoSmithKline plc Recent Development

7.2 Pfizer,Inc

7.2.1 Pfizer,Inc Company Information

7.2.2 Pfizer,Inc Introduction and Business Overview

7.2.3 Pfizer,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer,Inc Tetanus Vaccine Product Offerings

7.2.5 Pfizer,Inc Recent Development

7.3 Merck & Co.,Inc

7.3.1 Merck & Co.,Inc Company Information

7.3.2 Merck & Co.,Inc Introduction and Business Overview

7.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Merck & Co.,Inc Tetanus Vaccine Product Offerings

7.3.5 Merck & Co.,Inc Recent Development

7.4 Sanofi Pasteur SA

7.4.1 Sanofi Pasteur SA Company Information

7.4.2 Sanofi Pasteur SA Introduction and Business Overview

7.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sanofi Pasteur SA Tetanus Vaccine Product Offerings

7.4.5 Sanofi Pasteur SA Recent Development

7.5 Biological E

7.5.1 Biological E Company Information

7.5.2 Biological E Introduction and Business Overview

7.5.3 Biological E Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Biological E Tetanus Vaccine Product Offerings

7.5.5 Biological E Recent Development

7.6 Dano Vaccine &Biological Pvt.Ltd.,

7.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Information

7.6.2 Dano Vaccine &Biological Pvt.Ltd., Introduction and Business Overview

7.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Offerings

7.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Development

7.7 Panera

7.7.1 Panera Company Information

7.7.2 Panera Introduction and Business Overview

7.7.3 Panera Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Panera Tetanus Vaccine Product Offerings

7.7.5 Panera Recent Development

7.8 Shantha Biotechnics Ltd

7.8.1 Shantha Biotechnics Ltd Company Information

7.8.2 Shantha Biotechnics Ltd Introduction and Business Overview

7.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Product Offerings

7.8.5 Shantha Biotechnics Ltd Recent Development

8 Industry Chain Analysis

8.1 Tetanus Vaccine Industrial Chain

8.2 Tetanus Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Tetanus Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Tetanus Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Dano Vaccine &Biological Pvt.Ltd.,

Panera

Shantha Biotechnics Ltd

List of Tables

Table 1. Tetanus Vaccine Market Trends

Table 2. Tetanus Vaccine Market Drivers & Opportunity

Table 3. Tetanus Vaccine Market Challenges

Table 4. Tetanus Vaccine Market Restraints

Table 5. Global Tetanus Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Tetanus Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Tetanus Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Tetanus Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Tetanus Vaccine Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Tetanus Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Tetanus Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Tetanus Vaccine

Table 13. Global Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanus Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Tetanus Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Tetanus Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Tetanus Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Tetanus Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Tetanus Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Tetanus Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Tetanus Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Tetanus Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Tetanus Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Tetanus Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Tetanus Vaccine Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Tetanus Vaccine Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Tetanus Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Tetanus Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Tetanus Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Tetanus Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Tetanus Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Tetanus Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Tetanus Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Tetanus Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Tetanus Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Tetanus Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Tetanus Vaccine Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Tetanus Vaccine Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Tetanus Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Tetanus Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Tetanus Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Tetanus Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Tetanus Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Tetanus Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Tetanus Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Tetanus Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Tetanus Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Tetanus Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Tetanus Vaccine Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Tetanus Vaccine Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Tetanus Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Tetanus Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Tetanus Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Tetanus Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Tetanus Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. GlaxoSmithKline plc Company Information

Table 58. GlaxoSmithKline plc Introduction and Business Overview

Table 59. GlaxoSmithKline plc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. GlaxoSmithKline plc Tetanus Vaccine Product Offerings

Table 61. GlaxoSmithKline plc Recent Development

Table 62. Pfizer,Inc Company Information

Table 63. Pfizer,Inc Introduction and Business Overview

Table 64. Pfizer,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Pfizer,Inc Tetanus Vaccine Product Offerings

Table 66. Pfizer,Inc Recent Development

Table 67. Merck & Co.,Inc Company Information

Table 68. Merck & Co.,Inc Introduction and Business Overview

Table 69. Merck & Co.,Inc Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Merck & Co.,Inc Tetanus Vaccine Product Offerings

Table 71. Merck & Co.,Inc Recent Development

Table 72. Sanofi Pasteur SA Company Information

Table 73. Sanofi Pasteur SA Introduction and Business Overview

Table 74. Sanofi Pasteur SA Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Sanofi Pasteur SA Tetanus Vaccine Product Offerings

Table 76. Sanofi Pasteur SA Recent Development

Table 77. Biological E Company Information

Table 78. Biological E Introduction and Business Overview

Table 79. Biological E Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Biological E Tetanus Vaccine Product Offerings

Table 81. Biological E Recent Development

Table 82. Dano Vaccine &Biological Pvt.Ltd., Company Information

Table 83. Dano Vaccine &Biological Pvt.Ltd., Introduction and Business Overview

Table 84. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Offerings

Table 86. Dano Vaccine &Biological Pvt.Ltd., Recent Development

Table 87. Panera Company Information

Table 88. Panera Introduction and Business Overview

Table 89. Panera Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Panera Tetanus Vaccine Product Offerings

Table 91. Panera Recent Development

Table 92. Shantha Biotechnics Ltd Company Information

Table 93. Shantha Biotechnics Ltd Introduction and Business Overview

Table 94. Shantha Biotechnics Ltd Tetanus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Shantha Biotechnics Ltd Tetanus Vaccine Product Offerings

Table 96. Shantha Biotechnics Ltd Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Tetanus Vaccine Downstream Customers

Table 100. Tetanus Vaccine Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Tetanus Vaccine Product Picture

Figure 2. Global Tetanus Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Tetanus Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Tetanus Vaccine Sales Price (2019-2030) & (USD/Unit)

Figure 6. Tetanus Vaccine Report Years Considered

Figure 7. Global Tetanus Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Tetanus Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tetanus Vaccine Revenue in 2023

Figure 10. Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Diphtheria and tetanus (DT) vaccines Picture

Figure 12. Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines Picture

Figure 13. Tetanus and diphtheria (Td) vaccines Picture

Figure 14. Tetanus, diphtheria, and pertussis (Tdap) vaccines Picture

Figure 15. Global Tetanus Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Tetanus Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Tetanus Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Tetanus Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Tetanus Vaccine Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Adult

Figure 21. Product Picture of Pediatric

Figure 22. Global Tetanus Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Tetanus Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Tetanus Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Tetanus Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Tetanus Vaccine Price by Application (2019-2030) & (USD/Unit)

Figure 27. North America Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Tetanus Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Tetanus Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Tetanus Vaccine Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Tetanus Vaccine Sales Volume (%), (2019-2030)

Figure 39. United States Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 45. China Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 47. China Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 57. India Tetanus Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Tetanus Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 59. India Tetanus Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 60. Tetanus Vaccine Industrial Chain

Figure 61. Tetanus Vaccine Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions